Pacira BioSciences (PCRX) Price to Book (2011 - 2026)

Pacira BioSciences has reported Price to Book for 16 years, with the latest figure at 1.5 in Q2 2026.

• On a quarterly basis, Price to Book rose 6.17% year-over-year to 1.5 in Q2 2026; TTM through Jun 2026 was 1.5, a 6.17% increase from a year earlier, with the FY2025 full-year figure at 1.54, up 37.17% from the prior year.
• Price to Book was 1.5 for Q2 2026 at Pacira BioSciences, up from 1.36 in the prior quarter.
• The five-year high for Price to Book was 4.85 in Q1 2022, with the low at 0.93 in Q3 2024.
• Average Price to Book over 5 years is 2.0, with a median of 1.53 recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Price to Book slumped 49.61% in 2023, then jumped 64.33% in 2025.
• Over 5 years, Price to Book stood at 2.29 in 2022, then decreased by 21.23% to 1.8 in 2023, then slumped by 37.9% to 1.12 in 2024, then surged by 37.17% to 1.54 in 2025, then declined by 2.07% to 1.5 in 2026.
• The last three Price to Book figures came in at 1.5 (Q2 2026), 1.36 (Q1 2026), and 1.54 (Q4 2025), per Business Quant data.